Neutralizing monoclonal antibody mAb114 for Ebola virus disease (‎EVD)‎

Guidance for health care workers. Both the REGN-EB3 and mAb114 are recommended for use in EVD. The two drugs should not be given together. The choice of which monoclonal antibody to use depends on availability, including emerging information about effectiveness.